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Summary
Background Universal access to safe drinking water and sanitation facilities is an essential human right, recognised in 
the Sustainable Development Goals as crucial for preventing disease and improving human wellbeing. Comprehensive, 
high-resolution estimates are important to inform progress towards achieving this goal. We aimed to produce high-
resolution geospatial estimates of access to drinking water and sanitation facilities. 
Methods We used a Bayesian geostatistical model and data from 600 sources across more than 88 low-income and 
middle-income countries (LMICs) to estimate access to drinking water and sanitation facilities on continuous 
continent-wide surfaces from 2000 to 2017, and aggregated results to policy-relevant administrative units. We estimated 
mutually exclusive and collectively exhaustive subcategories of facilities for drinking water (piped water on or off 
premises, other improved facilities, unimproved, and surface water) and sanitation facilities (septic or sewer sanitation, 
other improved, unimproved, and open defecation) with use of ordinal regression. We also estimated the number of 
diarrhoeal deaths in children younger than 5 years attributed to unsafe facilities and estimated deaths that were averted 
by increased access to safe facilities in 2017, and analysed geographical inequality in access within LMICs.
Findings Across LMICs, access to both piped water and improved water overall increased between 2000 and 2017, with 
progress varying spatially. For piped water, the safest water facility type, access increased from 40·0% (95% uncertainty 
interval [UI] 39·4–40·7) to 50·3% (50·0–50·5), but was lowest in sub-Saharan Africa, where access to piped water 
was mostly concentrated in urban centres. Access to both sewer or septic sanitation and improved sanitation overall 
also increased across all LMICs during the study period. For sewer or septic sanitation, access was 46·3% (95% UI 
46·1–46·5) in 2017, compared with 28·7% (28·5–29·0) in 2000. Although some units improved access to the safest 
drinking water or sanitation facilities since 2000, a large absolute number of people continued to not have access in 
several units with high access to such facilities (>80%) in 2017. More than 253 000 people did not have access to sewer 
or septic sanitation facilities in the city of Harare, Zimbabwe, despite 88·6% (95% UI 87·2–89·7) access overall. 
Many units were able to transition from the least safe facilities in 2000 to safe facilities by 2017; for units in which 
populations primarily practised open defecation in 2000, 686 (95% UI 664–711) of the 1830 (1797–1863) units 
transitioned to the use of improved sanitation. Geographical disparities in access to improved water across units 
decreased in 76·1% (95% UI 71·6–80·7) of countries from 2000 to 2017, and in 53·9% (50·6–59·6) of countries for 
access to improved sanitation, but remained evident subnationally in most countries in 2017.
Interpretation Our estimates, combined with geospatial trends in diarrhoeal burden, identify where efforts to increase 
access to safe drinking water and sanitation facilities are most needed. By highlighting areas with successful 
approaches or in need of targeted interventions, our estimates can enable precision public health to effectively 
progress towards universal access to safe water and sanitation.
Funding Bill & Melinda Gates Foundation.
Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Introduction
WHO’s Integrated Global Action Plan for the Prevention 
and Control of Pneumonia and Diarrhoea emphasises 
the need for preventive measures.1 Unsafe water and 
unsafe sanitation were the first and second leading risk 
factors for under-5 mortality from diarrhoeal diseases 
globally in 2017.2 These risks increase susceptibility to the 
spread of infectious agents that cause diarrhoea, 
including rotavirus and Vibrio cholerae.3–6 They are also 
linked to the spread of neglected tropical diseases 
(NTDs),7–10 and adverse outcomes such as stunting, 
wasting, and underweight.11–13 Low access to safe water 
and sanitation has also been linked to broader social 
outcomes such as reductions in school attendance 
(particularly for girls who are menstruating), losses to 
economic productivity, and undue burden on women of 
time spent collecting water.14,15
Access to safe drinking water and sanitation are human 
rights,16 conferring benefits to human wellbeing beyond 
their impact on health. The global health and development 
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community has prioritised access by including safe 
water and sanitation targets in both the Millennium 
Development Goals and more recently in the Sustainable 
Development Goals (SDGs), in which the UN called for 
access to be universal (ie, 100% access) and equitable. 
Despite substantial expansion of access during the 
Millennium Development Goals era, it has been previously 
estimated that less than 75% of the population in many 
countries in sub-Saharan Africa and south and southeast 
Asia had access to improved facilities in 2017.17
Previous estimates of access have been reported 
primarily at the national level, as well as at the subnational 
level across Africa and for a subset of other countries.2,17–23 
The WHO and United Nations Children’s Fund 
(WHO–UNICEF) Joint Monitoring Programme (JMP) 
has analysed inequality of access by wealth quintile and 
urban-rural status, as well as within subnational regions 
for select locations.24,25 These analyses, however, do not 
provide comprehensive estimates over space and time 
across low-income and middle-income countries 
(LMICs) at fine spatial scales. Understanding variation in 
water and sanitation access in second administrative-
level units (eg, districts, counties; henceforth termed 
units) is imperative to identifying low-access areas at 
heightened risk of disease transmission,26,27 and areas 
that have successfully achieved high levels of access. 
Previous studies have used model-based geostatistics to 
map health indicators such as under-5 mortality,27 
diarrhoea incidence and prevalence,28 and child growth 
failure,29 along with sociodemographic factors such as 
educational attain ment,30 and interventions such as 
insecticide-treated bednet coverage31 and childhood 
Research in context
Evidence before this study
In light of the health risks associated with unsafe drinking 
water and sanitation, as well as broader considerations of 
human development, the Sustainable Development Goals 
(SDGs) included the target of universal access to safe facilities 
by 2030. The WHO and United Nations Children’s Fund 
(WHO–UNICEF) Joint Monitoring Programme estimates access 
to water and sanitation nationally and by urban and rural 
areas, while the Global Burden of Diseases, Injuries, and Risk 
Factors (GBD) study quantifies the health risks posed by unsafe 
water and sanitation nationally and for subnational regions in 
select countries. Although these and other efforts provide 
valuable insights, they mask local and cross-boundary variation 
and ultimately result in an incomplete picture of areas in 
greatest need of intervention. The limited availability of 
accurate and wide-ranging estimates monitoring local 
geographical inequalities presents a barrier to achieving 
universal access to safe water and sanitation facilities. Studies 
have used model-based geostatistics to map various health 
and sociodemographic factors, highlighting the potential to 
apply these methods for mapping access to water and 
sanitation across low-income and middle-income countries 
(LMICs).
Added value of this study
To our knowledge, this study presents the first high-resolution 
subnational estimates of access to safe drinking water and 
sanitation facilities across more than 88 LMICs and across all 
indicators of access from 2000 to 2017. Our Bayesian 
geostatistical models and extensive geolocated dataset account 
for spatial and temporal trends, and our suite of highly resolved 
spatial covariates leverage the relationships between access to 
water and sanitation and other variables for improved 
estimation. Additionally, this is the first application of ordinal 
regression methods on water and sanitation data at large 
spatial scales, allowing us to appropriately account for the 
mutually exclusive and collectively exhaustive (ie, accounting 
for 100% of the population) relationships between the relevant 
indicators of access. We report increasing access to safe facilities 
over time, but trends varied regionally, and many people 
continued to have no access to safe drinking water and 
sanitation facilities in 2017 across the LMICs studied. 
We estimate that 143 300 (95% uncertainty interval 
126 100–163 000) deaths of children younger than 5 years were 
attributable to unsafe water in sub-Saharan Africa in 2017, 
yet increases in access to safe water averted more than 18 100 
(15 700–21 200) child deaths in the region in that year. Averted 
child deaths were concentrated in select units that had great 
progress in access, while child diarrhoeal mortality increased in 
other units, probably due in part to decreases in access to piped 
water. Although geographical inequality decreased in most 
LMICs from 2000, in some cases the lowest level of access 
remained unchanged, effectively leaving behind some units, 
even as progress was made nationally.
Implications of all the available evidence
Despite considerable progress since 2000, geographical 
inequalities remain an obstacle to reaching the SDG target of 
universal access to safely managed facilities. Our estimates 
highlight where the most substantial improvements were 
achieved over time, identifying areas with successful strategies 
for adaptation elsewhere. Our identification of areas in which 
access to safe facilities is low, combined with high-resolution 
estimates of high diarrhoeal burden and child malnutrition 
prevalence, calls attention to communities with high 
susceptibility to the spread of infectious diseases. Although 
access to safe facilities is increasing in many countries, 
subnational inequalities point to the need for targeted 
interventions, particularly to reach communities with the 
lowest access and to increase access to the safest facility types. 
Our findings can inform local level monitoring of progress 
towards the SDG target, and provide a resource for decision 
makers to target areas most in need of additional resources.
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vaccines.32 We aimed to extend these methods to estimate 
access to safe drinking water and sanitation facilities at 
fine spatial resolutions.
Methods
Overview
To produce a comprehensive baseline of comparable 
estimates, we leveraged the indicators used by the JMP24 
and the Global Burden of Disease (GBD) study2 with a 
Bayesian geostatistical model. With use of data from 
600 unique datasets, we produced estimates of the relative 
(proportion) and absolute (number of people) access to 
water and sanitation facilities across continuous geog-
raphical surfaces and aggregated resulting predictions to 
national and subnational levels (reported as second 
administrative-level units) in more than 88 LMICs from 
2000 to 2017. We modelled access by facility-type indicators 
and for specific facilities with an ordinal modelling 
framework. We report regional results according to the 
GBD 2017 geographical hierarchy.2 We highlight specific 
types of transitions made in access to facility types and 
report the number of child diarrhoeal deaths attributed to 
unsafe facilities and averted by increased access to safe 
facilities. Finally, we present an analysis of variation in 
subnational geographical inequality in access.
Study design
We generated estimates for two sets of four mutually 
exclusive and collectively exhaustive indicators of access—
one set for drinking water and one for sanitation—with 
uncertainty intervals (UIs), from 2000 to 2017. Each set of 
four indicators collectively accounts for 100% of the 
population in the respective geographical area. We used 
an ordinal regression framework in which each indicator 
was modelled using an ensemble modelling framework 
for each country individually. We produced subnational-
level estimates for 88 LMICs for water and 89 LMICs for 
sanitation, first estimating continent-wide surfaces at a 
resolution of approximately 5 × 5 km, and then aggregating 
to second and first administrative and national boundaries. 
We included low, low-middle, and middle development 
countries, as classified by their Socio-demographic Index 
quintile,33 an indicator based on education, fertility, and 
income (appendix p 94). Despite their relatively high 
Socio-demographic Index, China and Libya were included 
to maintain geographical continuity. Countries were 
excluded if sufficient data were not available for reliable 
estimation with use of our modelling paradigm. A 
complete list of the countries included is available in the 
appendix (p 94). This study complied with the Guidelines 
for Accurate and Transparent Health Estimates Reporting 
(appendix p 93).34 Further details on methods and software 
used are available in the appendix (pp 9–11).
Data
Data were collated from Demographic and Health 
Surveys, Multiple Indicator Cluster Surveys, and other 
household surveys and censuses across 88 countries for 
water and 89 for sanitation from 2000 to 2017 (inclusion 
criteria details in appendix p 6). We used data from 
600 unique sources—501 for water and 457 for sanitation 
(some sources contained both water and sanitation data). 
For water, 60·2% of our data by weighted sample size 
comprised geopositioned points, and 69·3% of weighted 
sanitation data were points. All other data were areal data. 
Drinking water facilities were categorised as piped (piped 
on or off premises), other improved (protected wells 
and springs, bottled water, rainwater collection, bought 
water), unimproved (unprotected wells and springs), 
or surface water (figure 1). Sanitation facilities were 
categorised as sewer or septic (sewer or septic tanks), 
other improved (improved latrines, ventilated improved 
latrines, compos ting toilets), unimproved (flush toilets to 
open channels, unimproved latrines), or open defecation 
(figure 1), using standardised definitions from the JMP.17,24 
The resulting schema yielded mutually exclusive and 
collectively exhaustive indicators for water and sanitation 
access.17
Statistical analysis
To account for the ordinal data structure of the indicators 
of access for water (piped, other improved, unimproved, 
and surface water) and sanitation (sewer or septic, 
other improved, unimproved, and open defecation), this 
analysis used an ordinal continuation-ratio modelling 
strategy.35 This approach allows for the simultaneous 
modelling of mutually exclusive categorical responses, as 
shown in similar geospatial analyses.30,32 We first modelled 
the proportion of the population with access to sewer or 
septic sanitation using a binomial model. We then 
modelled the pr oportion of the population with access to 
other improved sanitation conditioned on not having 
access to sewer or septic sanitation. Subsequently, we 
modelled the proportion with access to unimproved 
sanitation conditioned on not having access to sewer 
or septic sanitation or other improved sanitation. The 
estimates from the second and third conditional models 
were then combined with the estimates from the first to 
generate a full set of estimates of access for all four 
indicators. In this manner, the estimates and their 
associated uncertainty incorporate the mutually exclusive 
and collectively exhaustive data structure. The same 
approach was used for the set of four indicators of access 
to drinking water facilities.
For each model used in this strategy, we used an 
ensemble modelling approach. Applying a stacking 
ensemble modelling approach, the data were initially fit 
with seven gridded-raster covariates (appendix p 28) to 
three independent models using a generalised additive 
model, boosted regression trees, and lasso regression. This 
generalised stacking approach has been successfully used 
in similar geospatial analyses of health and social data to 
optimise predictive performance.30,32 Predictions were 
generated from each of these child models to create raster 
See Online for appendix
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covariates to be used in the parent model. Subsequently, 
the data were fit with the raster covariates from the child 
models, with a binomial model using a spatially explicit 
mixed-effects generalised linear model via integrated 
nested Laplace approximation. Predictions were generated 
from this model by drawing 250 samples from the 
posterior distribution and taking the mean of these draws. 
The 95% UIs were generated by calculating the 2·5th and 
97·5th percentiles of the drawn samples. Uncertainty for 
estimates are presented for piped and improved water 
and sanitation indicators in the appendix (pp 39–42). To 
ensure our predictions were aligned with national-level 
temporal trends, we fitted a generalised additive linear 
model to nationally repre sentative data for each country. 
We calibrated the geospatial model to estimates from the 
national model by ensuring that, when aggregated to 
the national level, the geospatial estimates matched the 
corresponding esti mates from the national model. Model 
fits were assessed via five-fold cross-validation and 
calculating out-of-sample root-mean squared errors, bias, 
and 95% coverage for each model (appendix pp 10–11). 
Analyses were done with R, version 3.5.0. Maps were 
produced with ArcGIS Desktop 10.6. Further details for 
model specification and methods can be found in the 
appendix (pp 9–11).
We measured access as the proportion of the population 
accessing the corresponding water and sanitation facility 
type in a given geographical area at a specific time. To 
assess progress over time, we calculated the mean annual 
change from 2000 to 2017.
To assess the effect of changes in water and sanitation 
access on diarrhoeal disease mortality in children younger 
than 5 years, we used a comparative risk assess ment 
framework to construct counterfactuals and assess child 
deaths averted due to increased access.2 We used 
estimates of diarrhoeal mortality in children younger 
than 5 years available at the same spatial scales from the 
geospatial analysis described by Reiner and colleagues36 
for this counterfactual analysis; as such, only countries 
with data available from Reiner and colleagues were 
included. We combined these mortality estimates with 
risk ratios estimated in GBD 2017,2 which associated 
different types of water and sanitation facilities with 
varied risks of diarrhoeal disease. To use the risk ratios for 
different categories of water access from GBD, we 
combined our estimates of water access with household 
water treatment prevalence data from GBD to create 
concordant categories of water facility exposures. With 
these data, we calculated population attributable fractions 
of child diarrhoeal deaths to unsafe water and sanitation.2,26 
We then used access estimates in 2000 to calculate a 
counterfactual population attributable fraction. Using 
these population attributable fractions in conjunction 
with the Reiner and colleagues estimates of child 
diarrhoeal disease mortality across units,36 we calculated 
attributable under-5 deaths for water and sanitation in 
2017, as well as the number of averted child deaths in 2017 
due to changes in water and sanitation access since 2000. 
We propagated uncertainty by repeating the calculation 
for values from each of the 250 draws of the posterior 
from our model. This methodology is further outlined in 
the appendix (p 11).
Additionally, we estimated inequality using subnational 
variation across units and the Gini coefficient,37 which 
summarises the distribution of each indicator across the 
population, with a value of zero representing perfect 
equality and a value of one representing maximum 
inequality (appendix pp 11–12).
Role of the funding source
The funder had no role in study design, data collection, 
data analysis, data interpretation, or writing of the report. 
The corresponding author had full access to all the data 
in the study and had final responsibility for the decision 
to submit for publication.
Results 
Access to all facility-type indicators for drinking water 
varied spatially and temporally. Across all LMICs 
assessed, access to piped water increased between 
2000 and 2017 (from 40·0% [95% UI 39·4–40·7] to 50·3% 
[50·0–50·5] of the population), but this trend differed 
across regions (figure 2). Access to improved water overall 
increased from 82·6% (95% UI 82·3–82·8) in 2000 to 
87·0% (86·8–87·1) in 2017 (figure 2; appendix p 32). 
Access levels for each unit are presented in the appendix 
and online through our data visualisation tool.
Figure 1: Access to drinking water and sanitation indicators
The mutually exclusive and collectively exhaustive indicators modelled for water and sanitation. Each set of 
indicators collectively account for 100% of the population in the respective geographical area. The water indicators 
(piped on premises or piped off premises [piped], other improved, unimproved, and surface water) and the 
sanitation indicators (sewer or septic, other improved, unimproved, and open defecation) are outlined along with 
each indicator’s corresponding facility types. Facility types are categorised into the standardised indicators as 
defined by the WHO–UNICEF Joint Monitoring Programme to ensure concordance with global monitoring targets 
and comparability across locations. 
Piped water to inside household or to yard 
Facility types (water) Indicators
Piped on premises
Piped water to neighbour’s household, public stand pipe Piped off premises
Protected well, protected spring, rainwater, bottled water, tanker truck Other improved
Unprotected well, unprotected spring Unimproved
River, lake, canal, dam, surface water Surface water
Piped
Im
proved
Sewer
Facility types (sanitation) Indicators
Sewer
Septic tank Septic
Improved latrines, ventilated improved latrines, compost toilets Other improved
Unimproved latrines, bucket, hanging toilet Unimproved
No facility, bush Open defecation
Sew
er or septic
Im
proved
For the data visualisation tool 
see https://vizhub.healthdata.
org/lbd/wash
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Although access to piped water was lowest in sub-
Saharan Africa compared with other regions in 2017, 
notable areas of high access are apparent within sub-
Saharan Africa (figure 2). Across sub-Saharan Africa, at 
least 80% of the population had access (henceforth 
referred to as high access) to piped water in 2017 in 5·9% 
(95% UI 5·7–6·2) of units, but 54·0% (53·5–54·8) of 
units had decreases in piped water access from 
2000 to 2017, such as the Western Urban district of Sierra 
Leone (52·9% decrease [50·2–55·1]; figure 2). Units with 
high access to piped water facilities in sub-Saharan Africa 
mostly corresponded to large urban centres, such as 
Addis Ababa, Ethiopia (97·7% [95% UI 97·0–98·1]), and 
the Department of Guédiaway in Dakar, Senegal (92·9% 
[91·0–94·2]). However, in urban centres and other 
densely populated areas, a high absolute number of 
people continued to have no access even where unit-level 
access was high. For example, unit-level access to piped 
water was 90·5% (95% UI 85·2–95·3) in Casablanca, 
Morocco, yet 398 300 (198 500–618 500) people had no 
access. Large increases in piped water access also 
occurred from 2000 to 2017 for several African countries. 
In Niger, national-level piped water access increased 
from 23·5% (95% UI 22·7–24·4) to 47·6% (46·6–48·5), 
with a 1·3% mean annual percentage-point increase. In 
sub-Saharan Africa, 19·3% (95% UI 16·2–19·1) of units 
increased piped water access by more than 10 percentage 
points (figure 2). Access to improved water facilities 
overall was widespread in Africa, despite the relatively 
lower levels of piped water access: 56·8% (95% UI 
56·3–57·3) of units had high access (>80%) to improved 
water in 2017 (appendix p 32).
In south Asia, piped water access was relatively low, 
with just 8·5% (95% UI 7·8–9·2) of units with high 
access to piped water in 2017 (figure 2). However, 
improved water access overall was relatively high in the 
region, increasing from 83·1% (95% UI 82·9–83·3) in 
2000 to 92·5% (92·3–92·6) in 2017. Access to piped water 
was much higher in southeast Asia, east Asia, and 
Oceania in 2017, where 58·1% (95% UI 57·5–58·5) of 
units had high access. However, most of this piped water 
access was concentrated in China; when excluding 
China, access to piped water was just 3·2% (95% UI 
2·8–3·7) in the region. Access to improved water 
remained relatively stable in southeast Asia, east Asia, 
and Oceania over the study period. Access was 91·2% 
(95% UI 90·6–91·7) in 2000 and 88·7% (88·3–89·1) in 
2017. In southeast Asia, east Asia, and Oceania overall, 
access to improved water was high (>80%) in 77·0% 
(95% UI 76·1–77·8) of units in 2017, and the mean 
annual change in access was more than 2 percentage 
points in 7·1% (6·3–7·8) of units since 2000.
Access to piped water was relatively high in much of 
Latin America: 51·0% (95% UI 49·0–53·1) of units had 
high access to piped water in 2017 (figure 2). Improved 
water access increased in Latin America since 2000, from 
89·6% (89·3–89·7) to 93·2% (93·1–93·3). Individual units 
also had large increases in access to improved water—
eg, 96·4% (94·4–97·9) of units in Peru increased improved 
water access by more than 10 percentage points.
We sought to identify which units made transitions 
from no facility (ie, surface water or open defecation) in 
2000 to improved facilities in 2017, compared with more 
gradual transitions (from no facility to unimproved 
facilities, or unimproved to improved facilities) over the 
study period. To do so, we compared the most common 
type of water and sanitation access in each unit (access 
level of more than 60% of the population; figure 3). 
Across all LMICs, 397 (95% UI 371–428) units in 2000 had 
60% or more of their populations that relied on surface 
water. Of these, 176 (156–197) units had substantial 
upgrades—transitioning to 60% or more using improved 
facilities by 2017. In comparison, 780 (95% UI 741–825) 
units had 60% or more of people relying on surface water 
or 60% or more of people using unimproved facilities in 
2000; of these, relatively incremental upgrades (either 
from surface water to unimproved facilities, or from 
unimproved to improved water facilities) occurred in 
182 (95% UI 160–205) units. The full array of model 
outputs can be accessed online via our customised online 
visualisation tools.
We used a comparative risk assessment framework to 
estimate the number of deaths in children younger than 
5 years attributed to unsafe water and sanitation in 2017 
and the number of child deaths averted due to changes 
in access. In 2017, 143 300 (95% UI 126 100–163 000) 
deaths in children younger than 5 years in sub-Saharan 
Africa were attributable to unsafe water, and 18 100 
(15 700–21 200) child deaths were averted by increases in 
safe water access (figure 4). In southeast Asia, east Asia, 
and Oceania, 9470 (95% UI 8650–10 300) child deaths 
were attributable to unsafe water in 2017, whereas 
increases in safe water averted at least 1310 (1200–1440) 
child deaths in 2017.
Subnational disparities in access to improved drinking 
water and sanitation facilities, defined as the range of 
values from the unit with the highest level of access to 
the unit with the lowest level of access, are evident across 
LMICs (figure 5). For improved water, disparities 
decreased in 76·1% (95% UI 71·6–80·7) of LMICs from 
2000 to 2017. El Salvador and Mexico had among the 
greatest reductions in disparity for improved water, 
although absolute and relative inequalities still persisted 
in 2017; the lowest access in Mexico was 56·7% (95% UI 
29·8–77·1) less than the national mean in 2000 (3·0 times 
lower), and 20·8% (5·7–36·8) less than the mean 
(1·3 times lower) in 2017. Disparities in access 
to improved water changed in different ways across 
countries. In Ethiopia, the gap between the units with 
the lowest and highest access closed largely because the 
lowest level of access in 2000 drew closer to the highest 
level of access by 2017, increasing mean access to 
improved water nationally in 2017. By comparison, mean 
access to improved water was increased nationally in 
For the data visualisation tool 
see https://vizhub.healthdata.
org/lbd/wash
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A 2000
B 2017
C 2000
D 2017
Access to 
piped water (%)
100
50
0
Access to sewer 
or septic 
sanitation (%)
100
50
0
Figure 2: Access to piped 
water and sewer or septic 
sanitation at the second-
administrative-unit level, 
2000 and 2017
Access was modelled with use 
of model-based geostatistics 
for continuous continent-wide 
surfaces and aggregated to the 
second administrative level. 
The results for piped water are 
shown for years 2000 (A) and 
2017 (B). The results for sewer 
or septic sanitation are also 
shown for 2000 (C) and 
2017 (D). Maps reflect 
administrative boundaries, 
land cover, lakes, and 
population; dark grey-
coloured grid cells were 
classified as barren or sparsely 
vegetated and had fewer than 
ten people per 1 × 1-km grid 
cell, or were not included in 
these analyses.38–43 Interactive 
visualisation tools are available 
online. 
For the visualisation tools see 
https://vizhub.healthdata.org/
lbd/wash
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Mozambique by 2017, but the lowest access level was 
similar in 2000 and 2017, while the highest level of access 
increased, widening the total range. Inequalities as 
determined with use of the Gini coefficient revealed 
additional trends. In 2000, 25 LMICs had Gini coefficients 
that exceeded 0·15 for improved water access, whereas in 
2017, only nine remained higher than that level.
Access to sewer or septic sanitation across all LMICs 
increased from 28·7% (95% UI 28·5–29·0) in 2000 to 
46·3% (46·1–46·5) in 2017, whereas access to improved 
sanitation overall increased from 60·0% (59·8–60·1) to 
75·8% (75·7–75·9; figure 2, appendix p 36). Some 
regions saw large increases in access to sewer or septic 
sanitation since 2000, whereas access remained low 
across the study period in others.
Access to sewer or septic sanitation in sub-Saharan 
Africa was concentrated in similar areas to piped water, 
but just 1·0% (95% UI 1·0–1·0) of units had high access 
in the region, such as Bulawayo, Zimbabwe (96·5% 
access [95·8–97·1]; figure 2). In places with high unit-
level access, many individuals can remain without access 
to sewer or septic sanitation. For instance, despite 88·6% 
(87·2–89·7) of the population of Harare, Zimbabwe 
having access, more than 253 000 people did not have 
access in 2017.
In south Asia, there was high access to sewer or septic 
sanitation in 11·3% (95% UI 9·4–12·9) of units in 2017 
(figure 2). Improved sanitation overall had high unit-
level access in 69·0% (95% UI 67·6–70·4) of units in 
south Asia, increasing from a regional access level of 
29·4% (29·1–29·6) in 2000 to 79·4% (79·2–79·7) in 2017. 
Access to sewer or septic sanitation was higher in 
southeast Asia, east Asia, and Oceania compared with 
south Asia in 2017; 42·0% (95% UI 40·8–43·1) of units in 
the region had high access. Substantial increases in 
sewer or septic sanitation access occurred over the study 
period, such as in Rapti District, Mid-Western Region, 
Nepal, (49·3% [95% UI 43·5–54·9] increase; mean 
annual change of 2·7 percentage points). Unit-level 
access to improved sanitation was high in 67·8% 
(95% UI 66·8–69·0) of units in southeast Asia, east Asia, 
and Oceania, increasing from 81·6% (81·2–82·0) to 
85·9% (85·7–86·2) over the study period.
In Latin America, there was high access to sewer or 
septic sanitation in 32·8% (95% UI 31·7–33·8) of units 
in 2017 (figure 2). Latin America notably had an 11·8% 
increase in access to sewer or septic sanitation over the 
period (from 59·5% [59·3–59·8] to 71·3% [70·9–71·6]). 
Large increases occurred in sewer or septic sanitation 
from 2000, including in San Pedro Sula, Cortés, 
Honduras (increase of 35·9% [32·4–39·5], mean annual 
change of 2·0 percentage points). Access to improved 
sanitation overall was also high across the region, with 
more than half (54·5% [53·6–55·6]) of units in Latin 
America with high (>80%) access.
Of the 1830 (95% UI 1797–1863) units in which 60% 
or more of people practised open defecation in 2000, 
686 (664–711) transitioned substantially to having access 
to improved facilities in 2017 (figure 3). By contrast, 
580 (550–610) of the 5630 (5560–5690) units in which 
60% or more of people practised open defecation or 
in which 60% or more of people used unimproved 
facilities in 2000 transitioned incrementally by 2017. 
Subnation ally, many units in Ethiopia, such as Afder 
Zone, Somali, increased access to improved sanitation 
(11·6% [12·4–16·8] in 2000; 26·0% [22·8–29·0] in 2017) 
while substantially reducing open defecation (79·7% 
[77·0–82·1] in 2000; 43·3% [39·1–47·2] in 2017) over the 
period. Populations with high reliance on open defecation 
in 2017, were mostly concentrated in trans-border regions 
in southern Angola–northern Namibia and in west and 
central Africa.
According to our comparative risk assessment frame-
work, in 2017, 182 300 (95% UI 159 900–208 200) under-5 
child deaths in sub-Saharan Africa were attributed to 
unsafe sanitation, whereas increases in safe sanitation 
access averted at least 10 100 (8970–11 400) child deaths in 
the region (figure 4). In southeast Asia, east Asia, and 
Oceania, increases in safe sanitation averted at least 2750 
(95% UI 2530–3040) child deaths, with 7810 (7050–8700) 
child deaths attributable to unsafe sanitation in 2017, 
compared with 1840 (1660–2070) averted child deaths and 
4400 (4080–4690) child deaths attributable to unsafe 
sanitation in Latin America in 2017.
Subnational disparities in improved sanitation 
decreased in 53·9% (95% UI 50·6–59·6) of countries 
from 2000, and large decreases occurred in Vietnam and 
Cambodia, among other locations, although disparities 
were evident across LMICs in 2017 (figure 5). The lowest-
access unit in Cambodia was 4·9 times less than the 
national mean in 2000, and just 1·4 times less than in 
2017. Temporal trends in disparities varied in LMICs. In 
Namibia, mean access to improved sanitation increased 
overall from 2000 to 2017, but the lowest level of access 
remained relatively unchanged since 2000. Conversely, 
the highest level of access and the lowest level of access 
increased substantially in Cambodia over the study 
period. With use of the Gini coefficient, we found that 
many countries had consistent subnational inequality in 
improved sanitation, with Gini coefficients of more than 
0·15 in 37 LMICS in 2000 and 30 LMICs in 2017. Notably, 
Chad, Libya, and Togo had Gini coefficients of more 
than 0·35 in 2017.
Discussion
Access to safe drinking water and sanitation facilities has 
improved globally between 2000, and 2017, but disparities 
in access varied across LMICs, presenting a barrier to 
achieving the SDG goal of universal access (100% access). 
Many units, such as in Cambodia for drinking water, had 
sizeable transitions, with the great majority of the 
population relying on the lowest quality of facility types 
in 2000 but accessing improved facilities by 2017. These 
units are exemplars that merit further study to identify 
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Figure 3: Water and 
sanitation facility types used 
at the second-
administrative-unit level, 
2000 and 2017
The co-distribution of 
improved, unimproved, and 
no facility access is shown for 
water for 2000 (A) and 2017 
(B) and sanitation for 2000 
(C), and 2017 (D). Green 
denotes second 
administrative-level units 
where most of the population 
(>60%) had access to 
improved facilities, blue 
denotes a more than 60% 
reliance on unimproved 
facilities, and red denotes 
more than 60% relying or 
surface water in A and B or 
practicing open defecation in 
C and D. Yellow indicates that 
there was no single dominant 
facility type used by more than 
60% of the unit’s population. 
Maps reflect administrative 
boundaries, land cover, lakes, 
and population; dark grey-
coloured grid cells were 
classified as barren or sparsely 
vegetated and had fewer than 
ten people per 1 × 1-km grid 
cell, or were not included in 
these analyses.38–43 
A 2000 water
B 2017 water
C 2000 sanitation
D 2017 sanitation
Improved
No single dominant
facility type
Unimproved
Surface water
Improved
No single dominant
facility type
Unimproved
Open defecation
Articles
www.thelancet.com/lancetgh   Vol 8   September 2020 e1170
Figure 4: Effect of changes in 
access to water and 
sanitation in 2017 on child 
diarrhoeal deaths at the 
second-administrative-unit 
level
Deaths are calculated under 
the counterfactual scenario in 
which access to safe water and 
sanitation remained at the 
values observed in the 
year 2000. The number of 
deaths attributed given access 
levels observed in 2017 is 
shown for water (A) and 
sanitation (C). The number of 
deaths averted (shown in 
green) or caused (shown in 
purple) in 2017 due to changes 
in access levels compared with 
2000 is shown for water (B) 
and sanitation (D). Maps 
reflect administrative 
boundaries, land cover, lakes, 
and population; dark grey-
coloured grid cells were 
classified as barren or sparsely 
vegetated and had fewer than 
ten people per 1 × 1-km grid 
cell, or were not included in 
these analyses.38–43 
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drivers of success for replication elsewhere. In many 
countries, however, such progress was concurrent with 
increasing geographical inequality, as some units were 
effectively left behind. Our local-level estimates provide 
information to better target interventions to ensure 
progress towards greater access without increasing 
geographical inequality.
Estimates of access at the unit level support local 
monitoring of progress towards the SDG targets. Although 
our estimates of access to safe drinking water and 
sanitation facilities represent a best-case scenario of SDG 
attainment, in that they do not capture all the elements of 
safe management as defined by the JMP, even in the best-
case scenario it is evident that many locations will need to 
scale up access to attain the goal of universal coverage. 
These results also show that estimates of access stratified 
by urban or rural status only or at the first administrative 
level are likely to mask further localised heterogeneity. By 
providing estimates at the second administrative level, in 
which programmatic decisions are often made, our results 
enable local decision makers to target resources and 
programmes with greater precision. Given that household-
level water, sanitation, and hygiene interventions have had 
mixed results,44–46 these estimates can support targeting 
interventions at the community level to maximise 
efficiency and serve areas most in need of access.
Although increases in access to improved water 
facilities overall were observed in sub-Saharan Africa, 
access to piped water remained low in 2017. Decreases in 
piped water access were particularly apparent in some 
regions of sub-Saharan Africa, where demographic 
changes might be outpacing infrastructure development. 
The bulk of interventions in sub-Saharan Africa have 
focused on increasing access to improved wells or 
springs, and the relatively high rates of access to other 
improved water facilities in LMICs in 2017 indicates that 
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Figure 5: Geographical inequality in access to improved water and sanitation
Persistence of geographical inequality in access to improved facility types for water and sanitation and changes since 2000 are shown. Each bar’s height plots the level of access to improved water and 
sanitation, from the lowest to the highest access second administrative-level unit in 2000 (grey) and 2017 (coloured by region). Mean access at the national level is shown as grey dots. Colours 
correspond to Global Burden of Disease regions. Countries not shown were excluded from the study due to limited data availability. CAF=Central African Republic. COD=Democratic Republic of Congo. 
COG=Republic of Congo. DOM=Dominican Republic. GNQ=Equatorial Guinea. PNG=Papua New Guinea. 
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these interventions have largely been successful. Further 
investment in piped drinking water is needed to scale 
up and maintain access and to ensure consistent and 
quality access. Although initially costly, these efforts will 
ultimately improve economic productivity, supporting 
national development and stability.47,48
Our estimates revealed several units in which access to 
the safest facility types improved substantially. Exemplars 
in increasing piped water access include Svay Pao District, 
Battambang, Cambodia; Jantetelco Municipality, Morelos, 
Mexico; and Harari People’s National Regional State, 
Ethiopia. Alongside economic growth nationally, the 
autonomous Phnom Penh Water Supply Authority has 
been credited with substantial expansion of Cambodia’s 
urban piped water supply, whereas national and regional 
policy and government investment are likely to have 
played a role in Mexico and Ethiopia.49–51 Further research 
on successful interventions in these locations could help 
other units to adapt similar strategies. The same is true 
for exemplars of increased sewer or septic sanitation, 
including Kampong Chhnang District, Cambodia, and 
Bagmati Zone, Central Development Region, Nepal, 
where potential drivers include governance guided by 
national and regional policies, infrastructure construction 
and management, and (in the case of Nepal) social 
movements.52–55 Urbanisation gener ally leads to increased 
water and sanitation infra structure, although informal 
settlements in urban areas are often excluded, presenting 
a challenge to achieving equity in access.56 Although 
access to the safest facility types is lowest across sub-
Saharan Africa, several units have high access in the 
region. These exemplars indicate that increasing access to 
piped systems in sub-Saharan Africa is entirely possible, 
despite demands on infrastructure and long-term 
maintenance. Here, we consider the safest facilities to be 
those with the lowest health risk, defined as the lowest 
associated risk-ratio for diarrhoeal disease. Considerations 
of cost-effectiveness and logistical needs will probably 
influence what technology is the most appropriate for any 
single community, and these decisions can be more 
effectively made at the local level.
In countries where access to safer facilities increased 
only in units with existing access to improved facilities—
eg, transitioning from improved wells to piped—the 
population relying on the worst facility types was 
effectively left behind. Transitions to the safest facility 
type have the greatest potential to protect health 
compared with more moderate transitions.11,57 Improved 
facilities might not prevent environmental contamination 
and disease transmission after long-term use or in poor 
environmental conditions.58 Although piped water and 
sewer or septic sanitation have the greatest potential to 
prevent deaths from enteric diseases,2 piped systems are 
also susceptible to contamination,59 and water quality is 
not currently captured in our estimates. Despite having a 
smaller effect on health outcomes, transitions from 
surface water or open defecation to unimproved facilities, 
nonetheless represent important progress and potentially 
improved quality of life, including time saved for 
education and economic productivity.14,15 Decision makers 
would benefit from detailed local information on the 
differences in increases by type of access to better target 
future interventions.
Achieving universal access in line with the SDG target 
is likely to require tailored interventions framed within a 
broader focus on reducing disparities. Countries such as 
Mozambique were able to increase mean access to 
improved water facilities, but although the highest level 
of access increased, the lowest level was relatively stable 
from 2000 to 2017, potentially reflecting improvements 
concentrated in urban centres with large populations 
where access was already higher. Targeted rural inter-
ventions might be needed to serve those with the lowest 
levels of access, for whom increases in access have not 
been as substantial. Ethiopia, for example, was able to 
increase the lowest levels of access to improved water 
facilities by 2017. In remote com munities where a small 
number of people continue to have no access despite a 
high national access level, local-level investments in 
infrastructure are probably most suitable to address this 
disparity. Conversely, in Nigeria, where large numbers of 
people concentrated in single units do not have access 
to safe sanitation, more centralised solutions might 
best serve these dense urban populations. Examples such 
as improved water access in Cambodia, which saw 
pronounced increases in both the lowest access and 
highest access relative to 2000 levels, potentially present 
models for adoption elsewhere. Previous studies have 
identified poor, indigenous, and rural communities as 
the least likely to have access.51,60 Although the disparity 
in access between urban and rural areas has long been 
recognised, our estimates underscore the ongoing need 
for investment in rural water and sanitation.
Our results identified several units in which changes in 
access to safe water averted relatively few child deaths, or 
decreased access to safe water led to increased child 
diarrhoeal mortality. This finding largely reflects decreases 
in piped water access in some units—potentially driven in 
part by conflict and instability,61 particularly in areas such 
as in northeastern Nigeria—and suggests that what 
improvements in access did occur were not for the safest 
forms of facilities or that the improvements were not of a 
sufficient magnitude to have a major effect. In addition, 
our estimates do not capture other elements of safety, 
such as safe water storage and safe disposal of child faeces, 
which could drive reductions in diarrhoeal deaths.4 
Although the absolute number of deaths averted in a unit 
might not be large, the number of deaths attributable to 
unsafe water and sanitation in 2017 remains high, 
indicating that efforts to expand access would also reduce 
child mortality. Investments in increasing access to 
improved water and sanitation facilities are likely to have 
the greatest effect on reducing child deaths due to 
diarrhoea when coupled with other measures that protect 
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children.1,26 Other factors, such as treatment with oral 
rehydration solution, could have a combined effect with 
water and sanitation access on preventing child diarrhoeal 
deaths. Coverage of oral rehydration therapy over the 
study period has been mapped in a companion article by 
Wiens and colleagues.62 More broadly, strengthening 
primary health-care systems and addressing social and 
economic determinants of health will also be imperative 
to successfully reduce disease and prevent child deaths. 
Our estimates can help by identifying areas susceptible to 
disease spread, aiding vaccine-targeting efforts, and 
assisting disease elimination campaigns in focusing on 
where they will be most successful. The relationship 
between access to water and sanitation and the spread of 
NTDs provides a particular opportunity to coordinate and 
improve disease prevention efforts across sectors.10,63,64 
Water, sanitation, and hygiene are also integral to the 
treatment of some NTDs, such as lymphatic filariasis and 
podoconiosis.65,66 Our estimates facilitate targeting 
infrastructure investments toward communities with a 
high burden of NTDs, such as those identified through 
the Global Trachoma Mapping Project,67 and low levels of 
access to drinking water and sanitation facilities.
The geostatistical nature of this analysis allows for 
explicit incorporation of geopositioned data, more 
effectively capturing local variation in access over space 
and time, compared with studies that use exclusively 
areal data.13 Additionally, the use of a continuation-ratio 
modelling framework appropriately accounts for the 
ordinal relationships between indicators of water or 
sanitation facility type. This study also uses an extensive 
suite of covariates to leverage the complex relationships 
between water and sanitation access and environmental, 
social, and public health correlates at the local level. Our 
findings highlight the need to increase investment, 
assess existing interventions, scale up and expand 
successes, and improve monitoring of access to these 
facilities. Ultimately, these estimates, in combination 
with parallel work on oral rehydration therapy,62 provide 
an actionable atlas to progress toward universal access, 
reduce child diarrhoeal mortality and the spread of 
disease, and improve wellbeing worldwide.
The data and methodology underlying these results 
have several limitations. First, SDG 1.4.1 aims to achieve 
universal access to basic services, and SDG 6 aims to 
achieve universal access to safely managed services; 
however, current data are insufficient to produce reliable 
estimates of these dimensions of access at the spatial and 
temporal scale presented here. Consequently, this 
analysis focused on access by facility type classification 
(figure 1), and our estimates provide a best-case scenario 
for the SDGs (all improved facilities are safely managed 
and provide basic services). Second, despite the fine 
spatial resolution of this study, these results might not 
fully represent intra-urban disparities in water and 
sanitation. Third, to incorporate the vast quantity of areal 
data in a geostatistical framework, areal data were 
transformed into geopositioned point data over the 
corresponding geographical area. This method could 
result in smoothed estimates in areas with predominantly 
areal data. Fourth, our data do not capture the impacts of 
conflicts or climate change-related weather events and 
disasters, and data for locations affected by these factors 
might not reflect current conditions. Fifth, survey data 
are subject to known biases and inaccuracies in reporting, 
and these issues coupled with data scarcity in some 
locations could affect the accuracy of our estimates. 
Sixth, our analysis of inequality is limited to variation in 
access and does not encompass social and economic 
factors affecting inequality in access. Seventh, uncertainty 
in existing population estimates affects the precision of 
our count estimates of access. Finally, although our 
model generates estimates of uncertainty considering 
the covariates as well as spatiotemporal trends, un-
certainty is not explicitly incorporated from the survey 
design or the intermediate covariates generated from our 
stacking procedure (appendix p 9) due to computational 
limitations.
We plan to adopt the newly updated global indicators of 
water and sanitation access, including categories of basic 
and safely managed, by the WHO–UNICEF JMP. 
Although our study identified the best performing units 
and diverse modes of improvement across facilities, it 
was beyond our scope to identify the specific factors and 
interventions that contributed to these successes. Further 
research on potential shared characteristics across 
countries and units achieving high and equitable access 
could inform potential avenues for policy makers to 
adopt, particularly in light of the shifting focus from 
improved facility access to safely managed services. This 
analysis provides a comprehensive set of estimates across 
all facility types and locations; additional research with 
these methods to explore aspects presented here in 
greater detail would further enable prioritisation and 
targeting of water and sanitation interventions at the 
local level. 
Despite substantial gains in some regions, accelerated 
progress will be necessary to achieve universal and 
equitable access to the safest forms of drinking water and 
sanitation facilities in line with SDG targets. Sub-Saharan 
Africa, in particular, would probably benefit from a 
precision public health approach to increasing access. 
This analysis improves on traditional national and 
subnational estimates, providing an analysis of both 
absolute and relative progress and identifies communities 
with low access as well as exemplars of improved access 
at the second administrative level. Our results indicate 
that vast geographical inequalities persist in both the 
proportion and number of people with access within 
countries, as well as in improvements of the quality of 
facilities over time. Local estimates can guide targeting of 
disease prevention efforts, particularly vaccines and 
interventions for nutrition and NTDs, to the communities 
with the lowest access. Ultimately, our estimates provide 
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a resource for researchers, policy makers, and 
implementers to improve drinking water and sanitation 
access at local to national geographical scales, ensuring 
that all have access to this basic human right.
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